9:00am - 5:00pm

Our Opening Hours Mon. - Fri.

1.800.799.2234

Call Us For Free Consultation

Facebook

Twitter

Search
 

Sunitinib in Treating Patients With Advanced Malignant Pleural Mesothelioma

Top West Virginia Mesothelioma Lawyer | Law Firm | Attorney | GPW > Sunitinib in Treating Patients With Advanced Malignant Pleural Mesothelioma

Sunitinib in Treating Patients With Advanced Malignant Pleural Mesothelioma

Estimated reading time: < 1 min

Condition: Advanced Malignant Mesothelioma

Estimated Enrollment: 39

Gender: All

Min Age: 18 Years

Age Group: Adult, Older Adult

Current Status: Completed

Study Results: Has Results

Outcome Measures: Objective Response (Partial and Complete) Per RECIST,  ,  ,

Interventions: sunitinib malate,

Phase:

Study Type: Interventional

Study Design: Intervention Model: Single Group Assignment, Masking: None (Open Label), Primary Purpose: Treatment,

Primary Completion Date: January 2012

Completion Date: January 2012

Last  Posted Date: May 21, 2014

Location: National Cancer Institute of Canada Clinical Trials Group, Kingston, Ontario, Canada

Website Link: https://ClinicalTrials.gov/show/NCT00392444

Was this article helpful?
Dislike 0